Currently, the standard of care does not include injecting or prescribing unapproved experimental peptides for injuries there is no FDA approval or authoritative guideline endorsing BPC-157 use
Apr 16-22 2005;365(9468):1388
A highly effective option is a glutathione supplement containing Lipoglo Liposomal Glutathione 40%
These include 2 : Secukinumab (Cosentyx) (oral), a monoclonal antibody that blocks the action of an inflammatory cytokine
Advances in drug delivery systems, challenges and future directions
115 Glutathione deficiency is associated with chronic bronchitis, COPD, cystic fibrosis, idiopathic pulmonary fibrosis, bacterial and viral infections, and toxicity of various foreign compounds (smoke, pollutants, and drugs)